Evaluation of efficacy of Akashavalli in Non- Alcoholic Fatty Liver Disease.

Evaluation of Akashavalli (Cuscuta reflexa Roxb.) in Non-Alcoholic Fatty Liver Disease (NAFLD) Grade I and II- An exploratory clinical study.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051865

Enrollment

Registered

2023-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Non- Alcoholic Fatty Liver Disease (NAFLD) Grade I and II.

Exclusion criteria

Exclusion criteria: Known cases of diabetes mellitus, hypertension, thyroid dysfunctions. Known cases of any dysfunction of liver besides NAFLD like viral hepatitis, liver parenchymal disease, ascites, portal hypertension , hepato-cellular carcinoma, and liver transplantation or any condition interfering with the result of the treatment. Alcoholic fatty liver disease patient. Prior treatment with any medicine which affects the treatment of non-alcoholic fatty liver disease within 3 months.

Design outcomes

Primary

Measure	Time frame
Improvement in the Ultrasonography (USG) findings from Grade II to Grade I and from Grade I towards normal USG findings.Timepoint: 1 month trial followed by 1 month follow up	—

Secondary

Measure	Time frame
Improvement in Liver function tests and clinical presentation of patient.Timepoint: 1 month trial followed by 1 month follow up	—

Countries

India

Contacts

Public ContactDr Meena Deogade

All India Institute of Ayurveda, Sarita Vihar, New Delhi

tnesari@hotmail.com9958817145

Outcome results